IDEXX Laboratories, Inc.  

(Public, NASDAQ:IDXX)   Watch this stock  
Find more results for IDXX
86.40
-0.20 (-0.23%)
May 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 86.04 - 86.94
52 week 81.31 - 101.18
Open 86.94
Vol / Avg. 343,069.00/544,494.00
Mkt cap 4.67B
P/E 26.49
Div/yield     -
EPS 3.26
Shares 54.10M
Beta 1.08
Inst. own 101%
Jul 15, 2013
Q2 2013 Idexx Laboratories Earnings Release Add to calendar
May 8, 2013
Idexx Laboratories Annual Shareholder Meeting
Apr 23, 2013
Q1 2013 Idexx Laboratories Earnings Conference Call
Apr 22, 2013
Q1 2013 Idexx Laboratories Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 13.51% 13.79%
Operating margin 18.42% 20.30%
EBITD margin - 25.11%
Return on average assets 16.09% 16.71%
Return on average equity 28.39% 30.32%
Employees 5,400 -
Carbon Disclosure Rating - -

Address

One IDEXX Drive
WESTBROOK, ME 04092
United States - Map
+1-207-5560300 (Phone)
+1-207-5564346 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri.

Officers and directors

Jonathan W. Ayers Chairman of the Board, President, Chief Executive Officer
Age: 57
Bio & Compensation  - Reuters
Willard Blanche Jr. Acting Chief Financial Officer, Vice President - Finance
Age: 39
Bio & Compensation  - Reuters
William E. Brown III, Ph.D. Executive Vice President, Chief Scientific Officer
Age: 58
Bio & Compensation  - Reuters
Jeffrey A. Fiarman Executive Vice President, General Counsel
Age: 44
Bio & Compensation  - Reuters
Jay Mazelsky Executive Vice President
Age: 52
Bio & Compensation  - Reuters
Johnny D. Powers Ph.D. Executive Vice President
Age: 51
Bio & Compensation  - Reuters
Michael J. Williams Ph.D. Executive Vice President
Age: 45
Bio & Compensation  - Reuters
Daniel V. Meyaard Corporate Vice President - Worldwide Operations
Age: 55
Bio & Compensation  - Reuters
Giovani Twigge Corporate Vice President - Worldwide Human Resources
Age: 49
Bio & Compensation  - Reuters
Conan R. Deady Corporate Vice President, Secretary
Age: 51
Bio & Compensation  - Reuters